BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9923932)

  • 1. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.
    Neuhaus M; Wagner U; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Moch H; Mihatsch MJ; Gasser TC; Sauter G
    Hum Pathol; 1999 Jan; 30(1):81-6. PubMed ID: 9923932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH.
    Sauter G; Gasser TC; Moch H; Richter J; Jiang F; Albrecht R; Novotny H; Wagner U; Bubendorf L; Mihatsch MJ
    Urol Res; 1997; 25 Suppl 1():S37-43. PubMed ID: 9079755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
    Panani AD; Roussos C
    Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumours.
    Watters AD; Going JJ; Grigor KM; Bartlett JM
    Eur J Cancer; 2002 Aug; 38(12):1593-9. PubMed ID: 12142047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder.
    Watters AD; Ballantyne SA; Going JJ; Grigor KM; Bartlett JM
    BJU Int; 2000 Jan; 85(1):42-7. PubMed ID: 10619944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
    Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
    J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interphase cytogenetics of bladder cancer progression: relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome.
    Cianciulli AM; Bovani R; Leonardo F; Antenucci A; Gandolfo GM; Giannarelli D; Leonardo C; Iori F; Laurenti C
    Int J Clin Lab Res; 2000; 30(1):5-11. PubMed ID: 10984125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH: prognostic implications.
    Cianciulli AM; Bovani R; Leonardo C; Iori F; Coletta AM; Marzano R; Antenucci A; Gandolfo GM; Laurenti C
    Eur J Histochem; 2001; 45(1):65-71. PubMed ID: 11411867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
    Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
    J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
    Su JS; Arima K; Hasegawa M; Franco OE; Umeda Y; Yanagawa M; Sugimura Y; Kawamura J
    Int J Urol; 2004 Feb; 11(2):74-82. PubMed ID: 14706010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic aberrations of NAT2 and chromosome 8: their association with progression in transitional cell carcinoma of the urinary bladder.
    Watters AD; Stacey MW; Going JJ; Grigor KM; Cooke TG; Sim E; Bartlett JM
    Urol Int; 2001; 67(3):235-9. PubMed ID: 11598453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y chromosome loss is a frequent early event in urothelial bladder cancer.
    Minner S; Kilgué A; Stahl P; Weikert S; Rink M; Dahlem R; Fisch M; Höppner W; Wagner W; Bokemeyer C; Terracciano L; Simon R; Sauter G; Wilczak W
    Pathology; 2010 Jun; 42(4):356-9. PubMed ID: 20438408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
    Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG
    Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
    Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
    Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma.
    Hopman AH; Kamps MA; Speel EJ; Schapers RF; Sauter G; Ramaekers FC
    Am J Pathol; 2002 Oct; 161(4):1119-25. PubMed ID: 12368185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.
    Yamamoto Y; Matsuyama H; Furuya T; Oga A; Yoshihiro S; Okuda M; Kawauchi S; Sasaki K; Naito K
    Clin Cancer Res; 2004 Oct; 10(19):6449-55. PubMed ID: 15475431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.